{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Kronos Bio, Inc."},"Symbol":{"label":"Symbol","value":"KRON"},"Address":{"label":"Address","value":"1300 SO. EL CAMINO REAL,SUITE 300, SAN MATEO, California, 94402, United States"},"Phone":{"label":"Phone","value":"+1 650 781-5200"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine strategy by targeting dysregulated transcription."},"CompanyUrl":{"label":"Company Url","value":"https://www.kronosbio.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Charles Lin","title":"Senior Vice President-Research & Development"},{"name":"Deborah A. Knobelman","title":"President, CEO, COO & CFO"},{"name":"Elizabeth A. Olek","title":"Senior Vice President-Clinical Development"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}